AUAUniversity Podcast Series: Episode No. 36

Targeted Therapies In Renal Cell Carcinoma

Co-Host: Jay Raman, MD, FACS

At the conclusion of these activities, participants will be able to:
1. Review the mechanisms of action, efficacy, and safety of currently available targeted treatment of RCC.
2. Facilitate discussions with patients and caregivers regarding RCC treatment options.

This educational series is supported by independent educational grants from:
Amgen
Astellas
AstraZeneca
Bristol-Myers Squibb
Genomic Health
Merck
Pfizer, Inc.
Sanofi Genzyme
UroGen Pharma